Ethical Considerations for the Hatch-Waxman Practitioner: Discovery, Privilege, and Professional Responsibility

September 22, 2022 5:15pm

Tanzina Chowdhury
Senior Corporate Counsel
Nostrum Laboratories, Inc.

Shashank Upadhye
Upadhye Tang LLP
(Former Vice President – Global IP, Apotex, Inc.)

There is an ethical obligation as well as a fiduciary duty to protect the interest of your client – and Hatch-Waxman litigation has no exception to this general premise In this interactive session, our leaders will review common ethical challenges faced by Hatch-Waxman practitioners. Attendees will then reflect critically on hypothetical situations posed by the panelists, discuss in groups, and then review their conclusions.

  • Understanding how to maintain candid communication with the USPTO and fulfilling disclosure obligations
  • Exploring best practices to avoid inequitable conduct in the pharmaceutical patent litigation arena